Synthetic promoters to be developed for gene therapy in eye disease
Thu, 17/12/2015 - 11:00
Tue, 15/12/2015 - 12:00
A new £3.4 million programme will develop new tools to understand which interactions between proteins in the human body are relevant to disease.
Wed, 09/12/2015 - 12:00
GAINESVILLE, Fla., CAMBRIDGE, Mass.
Mon, 07/12/2015 - 09:00
Ongar, UK, 7th December 2015 / Sciad Newswire / Cypralis, a life sciences company focussed on the discovery of therapeutics for the modulation of peptidyl-prolyl
Thu, 05/11/2015 - 17:00
Collaboration aims to reduce the complexity, costs and time involved in CRISPR/Cas9 gene editing
Tue, 03/11/2015 - 15:00
London, UK, and San Francisco, USA, 3rd November 2015 / Sciad Newswire / SynbiCITE, the UK’s national centre for the industrialisation and commercialisation of sy
Mon, 02/11/2015 - 09:00
Ongar, UK, 2nd November 2015 / Sciad Newswire / Selcia has today announced that its spin out company Cypralis has been awarded co-funding by Innovate UK, the UK’s
Mon, 26/10/2015 - 14:00
San Francisco, USA, 26th October 2015 / Sciad Newswire / Ecovative and SynBioBeta announced today that they will be collaborating to provide fungal-derived stage
Tue, 20/10/2015 - 09:00
London, UK and Cambridge, UK, 20th October 2015 / Sciad Newswire / Domainex Ltd.
Thu, 15/10/2015 - 07:00
Belfast, UK, 15th October 2015 / Sciad Newswire / Queen’s University Belfast and Ulster University are joining forces with SynbiCITE, the UK’s Innovation and Know